CLINICALLY RECOMMENDED

Serial Number 97058190
Registration 6993104
700

Registration Progress

Application Filed
Oct 4, 2021
Under Examination
Oct 25, 2022
Approved for Publication
Aug 30, 2022
Published for Opposition
Aug 30, 2022
Registered
Feb 28, 2023

Trademark Image

CLINICALLY RECOMMENDED

Basic Information

Serial Number
97058190
Registration Number
6993104
Filing Date
October 4, 2021
Registration Date
February 28, 2023
Published for Opposition
August 30, 2022
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 28, 2023
Registration
Registered
Classes
005

Rights Holder

RECKITT HEALTH PAIN (US) LLC

16
Address
399 INTERPACE PARKWAY
PARSIPPANY, NJ 07054

Ownership History

Performance Health LLC

Original Applicant
16
Parsippany, NJ

Performance Health LLC

Owner at Publication
16
Parsippany, NJ

Performance Health LLC

Original Registrant
16
Parsippany, NJ

RECKITT HEALTH PAIN (US) LLC

New Owner After Registration #1
16
PARSIPPANY, NJ

Legal Representation

Attorney
Mark Lerner, Esq.

USPTO Deadlines

Next Deadline
1212 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-02-28)
Due Date
February 28, 2029
Grace Period Ends
August 28, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Oct 2, 2024 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 28, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 28, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 25, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 24, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jan 24, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 23, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 20, 2022 IUAF S USE AMENDMENT FILED Loading...
Dec 20, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 25, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 30, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 30, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 10, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 25, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 14, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 14, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 14, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 14, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 30, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Oct 29, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 7, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances, namely, topical preparations for the relief of aches, pain, discomfort and muscle soreness; analgesic balm; topical analgesics
First Use Anywhere: 20220200
First Use in Commerce: 20220200

Additional Information

Design Mark
The mark consists of the words "CLINICALLY RECOMMENDED" followed by the asterisk symbol all within a circle, with a check mark design at its center.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICALLY RECOMMENDED"